GLP-1-based therapies offer a pharmacological intervention that targets these mechanisms directly, allowing for more effective management of obesity
What the research shows To explore whether GLP-1 medications are associated with increased risk of gastrointestinal conditions, a recent study compared over 200,000 individuals taking GLP-1 medications with a group taking other type 2 diabetes medications (1)
These signs could indicate neurological conditions such as hemifacial spasm, Bells palsy, or even rarer disorders affecting the facial nerves
It binds to toxins and heavy metals, facilitating their elimination from the body
Heres how it can help: Reduced Pain and Swelling : By targeting the source of inflammation, Semaglutide can alleviate pain and swelling, especially in conditions like arthritis
Others find that phentermine works brilliantly for appetite control but hate the stimulant-like side effects